Clinical Trial Update: A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the pharmacokinetic and pharmacodynamic properties of BioChaperone Insulin Lispro, Fiasp, and NovoRapid delivered by an insulin pump …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• BioChaperone Insulin Lispro (insulin lispro)
• Fiasp (insulin aspart)
• NovoRapid (insulin aspart)

Snippet

Sponsor: Adocia | Conditions: Type1 Diabetes Mellitus | Phase 1 | Status: COMPLETED